BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/21/2020 2:15:44 PM | Browse: 703 | Download: 1266
 |
Received |
|
2020-01-31 03:23 |
|
Peer-Review Started |
|
2020-01-31 03:25 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-02-27 02:47 |
|
Revised |
|
2020-06-06 18:17 |
|
Second Decision |
|
2020-06-09 08:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-06-10 17:45 |
|
Articles in Press |
|
2020-06-10 17:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-19 06:03 |
|
Publish the Manuscript Online |
|
2020-06-21 14:15 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Medications in type-2 diabetics and their association with liver fibrosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohamed Tausif Siddiqui, Hina Amin, Rajat Garg, Pravallika Chadalavada, Wael Al-Yaman, Rocio Lopez and Amandeep Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amandeep Singh, MD, Attending Doctor, Staff Physician, Department of Gastroenterology and Hepatology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, 9500 Euclid Ave Suite-A5, Cleveland, OH 44195, United States. singha4@ccf.org |
| Key Words |
Diabetes medications; Anti-lipid medications; Antihypertensive medication; Fatty liver; Advanced fibrosis; |
| Core Tip |
Prevalence of non-alcoholic fatty liver disease is increasing worldwide. Certain medication such as HMG-CoA reductase inhibitors (statins) and Angiotensin converting enzyme inhibitors have been shown to be associated with reduction in advanced fibrosis in viral hepatitis patients. Patients with type 2 diabetes are at higher risk of developing advanced fibrosis. Given that these patients require lifelong medications to treat type 2 diabetes we sought to analyze their association with biopsy proven liver fibrosis. By doing so we hope that our findings will help researchers in the future explore and design prospective studies to further enhance our understanding of this field. |
| Publish Date |
2020-06-21 14:15 |
| Citation |
Siddiqui MT, Amin H, Garg R, Chadalavada P, Al-Yaman W, Lopez R, Singh A. Medications in type-2 diabetics and their association with liver fibrosis. World J Gastroenterol 2020; 26(23): 3249-3259 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i23/3249.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i23.3249 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
